KEGG: mpn:MPN214
MPN_214 protein is referenced through several different identifiers in scientific literature and databases:
| Identifier Type | Value |
|---|---|
| Gene Name | MPN_214 |
| Synonyms | MG076 homolog; G07_orf138; MP617; Uncharacterized protein MG076 homolog |
| UniProt ID | P75555 |
| Common Product Code | RFL30111MF (for recombinant version) |
This diversity of identifiers reflects the protein's appearance across different annotation systems and genomic analyses of Mycoplasma pneumoniae . Researchers should be aware of these alternative identifiers when conducting literature searches to ensure comprehensive coverage.
MPN_214 represents an interesting case study in Mycoplasma evolution. Mycoplasmas are distinctive bacteria that evolved through dramatic genome reduction, resulting in some of the smallest genomes among free-living organisms . Despite this reduction, Mycoplasma pneumoniae maintains repetitive elements in its genome, suggesting selective pressure to retain certain genetic features.
As an uncharacterized protein, MPN_214 may represent a conserved function specific to Mycoplasma biology. The retention of this gene through evolutionary genome minimization suggests it likely serves an important function, possibly related to the unique parasitic lifestyle of these cell wall-less bacteria . Understanding MPN_214 may provide insights into core functions that were retained during the reductive evolution of Mycoplasma species.
The recombinant MPN_214 protein requires specific handling procedures to maintain stability and functionality:
Storage Recommendations:
Store lyophilized powder at -20°C/-80°C upon receipt
Aliquoting is necessary for multiple use to avoid repeated freeze-thaw cycles
Working aliquots can be stored at 4°C for up to one week
Long-term storage requires 5-50% glycerol (50% is recommended) as a cryoprotectant
Buffer Conditions:
The protein is typically supplied in Tris/PBS-based buffer with 6% Trehalose, pH 8.0
This buffer formulation helps maintain protein stability while in lyophilized form
Repeated freeze-thaw cycles should be avoided as they can lead to protein degradation and loss of activity. These storage recommendations are based on established protocols for maintaining the structural integrity of recombinant proteins expressed in E. coli systems.
For optimal reconstitution of lyophilized MPN_214 protein:
Centrifuge the vial briefly before opening to bring all contents to the bottom
Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL
For long-term storage, add glycerol to a final concentration of 5-50% (50% is recommended)
Aliquot the reconstituted protein to minimize freeze-thaw cycles
This reconstitution method optimizes protein solubility while minimizing potential degradation. The addition of glycerol serves as a cryoprotectant to prevent damage during freezing. Researchers should perform a test reconstitution with a small amount of protein to verify solubility before processing the entire sample.
The verification of MPN_214 protein purity and integrity should follow standard protein characterization methods:
SDS-PAGE Analysis:
The recombinant protein typically shows greater than 90% purity as determined by SDS-PAGE
The expected molecular weight can be calculated from the amino acid sequence (approximately 15-16 kDa for the core protein plus additional weight for the His-tag)
Western Blot:
Anti-His antibodies can detect the His-tagged protein
This approach confirms both the presence and expected size of the tagged protein
Mass Spectrometry:
For confirmation of protein identity, tryptic digest followed by mass spectrometry can verify the amino acid sequence
This approach is particularly valuable for uncharacterized proteins to confirm their identity
Researchers should include positive controls (other His-tagged proteins) and negative controls (non-tagged proteins) when performing these verification steps to ensure specificity of detection methods.
Intron analysis methodologies represent a sophisticated approach to studying genetic variation in Mycoplasma species, applicable to MPN_214 research:
PCR Amplification Strategy:
Previous studies on Mycoplasma species have revealed that PCR amplification of nuclear small subunit ribosomal DNA (nrSSU rDNA) can yield fragments with unexpected sizes due to the presence of group I introns . For MPN_214, researchers could:
Design primers flanking the complete MPN_214 coding region
Compare amplicon sizes across different Mycoplasma strains to detect potential introns
Sequence variants to identify insertion positions within the gene
Intron Presence/Absence Analysis:
Studies have demonstrated that the presence or absence of introns serves as a valuable marker for examining population structure in related organisms . This approach could be applied to MPN_214 to:
Determine if MPN_214 contains introns across different Mycoplasma pneumoniae strains
Use the patterns of intron presence/absence to infer evolutionary relationships
Correlate intron patterns with functional variations in the protein
This methodology has previously identified distinct size classes (Class I, II, and III) in related genes, with variations in the number and position of introns . Similar patterns might exist in MPN_214, providing insights into the gene's evolution and population genetics.
When designing experiments to investigate the function of uncharacterized proteins like MPN_214, several critical considerations must be addressed:
Sex as a Biological Variable:
Statistical power analysis should be performed to determine appropriate sample sizes when designing animal experiments
Analysis of variance (ANOVA) approaches can help determine if sex influences protein function or expression
Reporting should include effect sizes (partial eta²) and power calculations as shown in the following reference table:
| Analysis Type | Effect Size (f) | Power (1-β) | Sample Size for Power ≥0.8 |
|---|---|---|---|
| Main effect of sex | 0.383 | 0.225 | 56 (28M, 28F) |
| Dose x sex interaction | 0.553 | 0.657 | 16 (8M, 8F) |
This approach ensures sufficient statistical power to detect sex-specific effects in functional studies .
Cell Line Selection:
Given that MPN_214 is expressed in E. coli for recombinant production , researchers should consider:
Using multiple expression systems to verify function (bacterial, yeast, mammalian)
Testing function in cell lines relevant to Mycoplasma pneumoniae infection (respiratory epithelial cells)
Designing controls that account for tag-related artifacts (comparing His-tagged vs. untagged versions)
Functional Prediction Approaches:
Leverage comparative genomics with other Mycoplasma species
Apply structural prediction tools to identify potential functional domains
Consider evolutionary conservation patterns to infer functional constraints
These design considerations ensure robust experimental frameworks capable of generating reliable insights into the function of this uncharacterized protein.
Restriction Fragment Length Polymorphism (RFLP) analysis offers a powerful approach to studying genetic variation in MPN_214 across different populations:
RFLP Methodology for MPN_214:
Amplify the MPN_214 gene and associated regions using PCR
Select appropriate restriction enzymes based on predicted cut sites within the sequence
Analyze fragment patterns to identify genotype variations
Apply statistical methods like Analysis of Molecular Variance (AMOVA) to quantify population subdivision
Previous studies on related organisms have revealed significant insights through this approach. For example, RFLP analysis of ITS regions in Cladonia arbuscula identified distinct genotypes that helped infer dispersal mechanisms . Similar approaches with MPN_214 could:
Identify population-specific variants of MPN_214
Help understand the evolutionary pressures on this gene
Reveal potential structural variations that might influence protein function
This methodology is particularly valuable for uncharacterized proteins like MPN_214, as it can identify natural variants that might indicate functional constraints or adaptations across different environments or host populations.
When analyzing experimental data related to MPN_214, researchers should employ rigorous statistical methods appropriate for the experimental design:
For Gene Expression Studies:
Two-way ANOVA is recommended when examining effects of multiple factors (e.g., sex, treatment) on MPN_214 expression
Report F-statistics, degrees of freedom, p-values, effect sizes, and power analyses
For example: F (1,10) = 4.34, p = 0.0639, partial eta² = 0.383, power = 0.225
For Population Genetics:
Analysis of Molecular Variance (AMOVA) can determine population subdivision
Report the percentage of variation explained by different hierarchical levels
Interpret population structure in the context of geographical or environmental factors
For Protein Function Analysis:
When comparing wildtype vs. mutant forms, appropriate parametric or non-parametric tests should be selected based on data normality
Multiple testing corrections (e.g., Bonferroni, FDR) should be applied when conducting numerous comparisons
Power analysis should be performed to ensure adequate sample size
These statistical approaches ensure robust interpretation of experimental results and facilitate meaningful comparisons with other studies in the literature.
Predicting the function of uncharacterized proteins like MPN_214 requires an integrated bioinformatic approach:
Sequence-Based Prediction:
Conduct Basic Local Alignment Search Tool (BLAST) searches against well-characterized protein databases
Identify conserved domains using InterPro, Pfam, or PROSITE
Perform multiple sequence alignments with homologs to identify conserved residues
Structural Prediction:
Use tools like AlphaFold or I-TASSER to predict 3D structure
Identify structural motifs that might suggest function
Analyze potential binding pockets or active sites
Genomic Context Analysis:
Examine neighboring genes in the Mycoplasma pneumoniae genome
Identify potential operons or functionally related gene clusters
Compare synteny across different Mycoplasma species
Evolutionary Analysis:
Construct phylogenetic trees to understand evolutionary relationships
Analyze selective pressure (dN/dS ratios) to identify functionally important regions
Consider the significance of MPN_214's retention despite Mycoplasma's genome reduction
By integrating these approaches, researchers can develop testable hypotheses about MPN_214's function that can guide subsequent experimental validation.
Interpreting protein-protein interaction (PPI) data for uncharacterized proteins like MPN_214 requires careful consideration of several factors:
Experimental System Limitations:
His-tagged versions of MPN_214 might exhibit altered interaction profiles compared to native protein
E. coli expression systems may lack post-translational modifications present in Mycoplasma
Buffer conditions during experiments can significantly influence interaction detection
Statistical Validation:
Apply appropriate statistical tests to distinguish true interactions from background
Consider using scoring systems that integrate multiple lines of evidence
Report false discovery rates and confidence intervals
Biological Context:
Interpret interactions in light of Mycoplasma pneumoniae's minimal genome
Consider the cell wall-less nature of Mycoplasmas when evaluating membrane-related interactions
Assess whether interactions are conserved across different Mycoplasma species
Validation Approaches:
Confirm key interactions using multiple methodologies (pull-down, co-immunoprecipitation, FRET)
Perform domain mapping to identify specific interaction regions
Validate biological relevance through functional assays
These considerations help ensure that PPI data for MPN_214 is interpreted accurately, leading to reliable insights into the protein's function within the Mycoplasma pneumoniae cellular network.
PCR amplification of Mycoplasma genes, including MPN_214, presents several challenges that researchers should anticipate:
Challenge: Unexpected Fragment Sizes
Previous studies with Mycoplasma genes have revealed PCR products significantly larger than expected due to the presence of introns. For example, amplification of nrSSU rDNA revealed fragments that were 200, 400, and 600 nucleotides longer than anticipated .
Solution:
Design primers that account for potential intron locations
Use long-range PCR enzymes capable of amplifying larger fragments
Verify product identity through sequencing rather than relying solely on band size
Challenge: Group I Introns
The presence of putative group I introns at specific positions (e.g., position 1624 and 1777 in nrSSU rDNA) can complicate amplification and analysis .
Solution:
Design primers that flank potential intron sites
Consider using nested PCR approaches to improve specificity
Analyze sequence data carefully to identify intron-exon boundaries
Challenge: Population-Level Variation
Studies have shown that even closely located populations can show distinct genetic profiles, complicating interpretation .
Solution:
Include multiple isolates from each study site
Characterize population structure before making functional inferences
Use appropriate statistical approaches like AMOVA to quantify variation
These approaches can help researchers overcome common challenges in Mycoplasma gene amplification and ensure reliable results when working with MPN_214.
Optimizing the expression and purification of recombinant MPN_214 involves several key considerations:
Expression System Optimization:
The current protocol uses E. coli expression with an N-terminal His tag
Consider testing different expression systems:
Different E. coli strains (BL21, Rosetta for rare codons)
Alternative tags (GST, MBP) that may improve solubility
Inducible promoters with variable induction conditions
Purification Optimization:
For His-tagged MPN_214, nickel affinity chromatography is the primary purification method
Consider these optimization steps:
Test different imidazole concentrations in wash and elution buffers
Add low concentrations of detergents if hydrophobic regions cause aggregation
Include reducing agents if cysteine residues might form disulfide bonds
Storage Buffer Optimization:
Current recommendations include:
5-50% glycerol for long-term storage
Additional optimizations might include:
Testing different pH values (7.0-8.5)
Adding stabilizing agents like low concentrations of reducing agents
Determining optimal protein concentration to prevent aggregation
Quality Control Measures:
Dynamic light scattering to assess aggregation state
Circular dichroism to verify proper folding
These optimization strategies can help researchers maximize yield and maintain the structural integrity of recombinant MPN_214 protein for functional studies.
Addressing stability issues with recombinant MPN_214 requires systematic troubleshooting based on the protein's characteristics:
Preventing Freeze-Thaw Damage:
Current recommendations advise against repeated freeze-thaw cycles
Implementation strategies include:
Preparing single-use aliquots immediately after purification
Storing working aliquots at 4°C for up to one week
Using controlled freezing rates to minimize ice crystal formation
Addressing Aggregation:
The highly hydrophobic regions in MPN_214's sequence suggest potential aggregation issues
Mitigation approaches include:
Adding mild, non-ionic detergents (0.01-0.1% Triton X-100 or NP-40)
Optimizing protein concentration (typically keeping below 1 mg/mL)
Including solubilizing agents like arginine or trehalose
Oxidative Damage Prevention:
The presence of cysteine residues (position 71 in the sequence) suggests potential sensitivity to oxidation
Preventive measures include:
Adding reducing agents (DTT, β-mercaptoethanol, or TCEP)
Ensuring buffers are degassed and containers are filled to minimize air contact
Including antioxidants like EDTA to chelate metal ions that catalyze oxidation
Stability Monitoring:
Implement regular quality control:
Size-exclusion chromatography to detect aggregation
Activity assays to verify functional integrity over time
Mass spectrometry to identify potential degradation products
By implementing these approaches, researchers can significantly improve the stability and reproducibility of experiments utilizing recombinant MPN_214 protein.